NCT03049449 2023-01-18T Cells Expressing a Fully-Human Anti-CD30 Chimeric Antigen Receptor for Treating CD30-Expressing LymphomasNational Institutes of Health Clinical Center (CC)Phase 1 Completed26 enrolled 19 charts
NCT01384513 2022-11-17A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological MalignanciesThomas Jefferson UniversityPhase 2 Completed40 enrolled